1,25(OH)2D3
|
1,25-dihydroxyvitamin D3
|
5-FU |
5-Fluorouracil |
ABC |
ATP binding cassette |
AMPK |
AMP-activated protein kinase |
BMP |
Bone morphogenetic protein |
CAMKK |
Calcium/calmodulin-dependent protein kinase kinase |
CMF |
Cyclophosphamide—Methotrexate—5-Flurouracil |
CR |
Cytokine receptor |
CSCs |
Cancer stem cells |
CTR1 |
Copper transporter 1 |
FDA |
Food and Drug Administration |
FOLFOX |
5-Flurouracil—Folinic acid—Oxaliplatin |
HIF1α |
Hypoxia-Inducible factor 1-α |
LKB1 |
Liver-kinase B1 |
MATE |
Multidrug and toxic compound extrusion |
mTOR |
Mammalian target of rapamycin |
OCT |
Organic cation transporter |
P-gp |
P-glycoprotein |
PCa |
Pancreatic cancer |
ROS |
Reactive oxygen species |
RXR |
Retinoid X receptor |
TGF-β |
Transforming growth factor-β |
TKI |
Tyrosine kinase inhibitor |
Trx |
Thioredoxin |
TrxR |
Thioredoxin reductase |
TXNIP/VDUP1 |
Thioredoxin-interacting protein/vitamin D3-upregulated protein 1 |
VDR |
Vitamin D receptor |
VDRE |
Vitamin D response elements |